OPKO’S GeneDx Announces Research Collaboration with Radboud University Medical Center

MIAMI, Jan. 12, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK), announces today that GeneDx, Inc., a subsidiary of OPKO’s BioReference Laboratories, has entered into a research collaboration with the Radboud University Medical Center, Nijmegen, Netherlands. Through the agreement, GeneDX and Radboud aim to identify novel genes and pathways to help understand the causes, clinical characteristics, and eventual management of human genetic diseases. […]

OPKO’s BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care

MIAMI and ORLANDO, Fla., Sept. 19, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK) (“OPKO” or “the Company”), announces that BioReference Laboratories, an OPKO Health company and one of the largest commercial laboratories in the U.S., has formed a national affiliation with The Garage, a dynamic, healthcare technology change agent, to provide clinicians with advanced tools to guide quality, value-based care. BioReference Laboratories is led by pathologists […]

OPKO’s GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings

MIAMI, Sept. 12, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ:OPK) (“OPKO” or “the Company”) announces that GeneDx will be showcasing its leadership in genetic and genomic testing with more than 35 poster and platform presentations at the National Society of Genetic Counselors (NSGC) and the American Society of Human Genetics (ASHG) annual meetings this fall. At the 36th Annual National Society of Genetic Counselors […]

OPKO’S GeneDx Extends Relationship with University of California Health for Genetic and Molecular Testing

MIAMI, June 07, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (Nasdaq:OPK) announced today that GeneDx, a business unit of OPKO’s BioReference Laboratories division, extended its relationship with the University of California Health (UC Health) for genetic, genomic, and molecular testing services. UC Health, one of the nation’s leaders in genomics and precision medicine in both the clinical and investigational arenas, has selected GeneDx to supplement […]

OPKO Health’s 4Kscore® Test Highlighted in Podium Presentation at 112th American Urological Association Annual Meeting

MIAMI, May 18, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK), announces that data from a prospective study conducted at Veteran Affairs (VA) hospitals confirming the 4Kscore test’s ability to accurately predict aggressive prostate cancer were presented in a podium presentation on May 16, 2017 at the 112thAmerican Urological Association (AUA) Annual Meeting in Boston. The study entitled, “An Independent, Multi-Institutional, Prospective […]

OPKO Subsidiary GenPath Women’s Health Announces the Availability of ClariTest™

MIAMI, March 07, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ:OPK) announces that GenPath Women’s Health, a business unit of OPKO Health subsidiary BioReference Laboratories, will offer ClariTest™, a non-invasive prenatal test (NIPT) initially to be performed at Illumina, Inc. (NASDAQ:ILMN) on the Verifi™ platform.  This platform utilizes massively parallel sequencing technology to screen for trisomies 13, 18, 21 and sex chromosome abnormalities, with […]

OPKO Health’s GeneDx to have Significant Presence at ACMG 2017

Launching New Genetic Tests in Multiple Indications Multiple Poster and Platform Presentations Highlight GeneDx’ Broad Offerings in a Variety of Genetic Specialties MIAMI, March 14, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ:OPK)   announces that GeneDx, a subsidiary of OPKO Health, will have a prominent presence at  the American College of Medical Genetics and Genomics (ACMG) Annual Meeting taking place from March 21-24, […]

OPKO Health’s GeneDx Announces Participation in Illumina’s iHope Program on International Rare Disease Day

MIAMI, Feb. 28, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK), today announces that GeneDx, a subsidiary of OPKO Health, is proud to participate as a founding member in Illumina Inc.’s (NASDAQ:ILMN) iHope Network on International Rare Disease Day, which takes place today.  iHope Network is led by a group of clinical laboratory partners committed to providing clinical whole-genome sequencing (cWGS) to […]

OPKO Health Appoints Dr. Benjamin Solomon as Managing Director of GeneDx

MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (NASDAQ:OPK), announces the appointment of Benjamin D. Solomon, M.D. as Managing Director of GeneDx, effective as of October 3, 2016. GeneDx, part of OPKO’s BioReference Laboratories subsidiary, specializes in genetic testing for rare hereditary disorders. Dr. Solomon is a pediatric geneticist who focuses on the use of genetics and genomics to identify, understand and care for patients […]

OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories

MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (Nasdaq: OPK) announces the appointment of Jane Pine Wood, Esq. as Chief Legal and Compliance Officer of its wholly owned subsidiary, BioReference Laboratories, effective October 1, 2016. Ms. Wood is a nationally respected healthcare attorney who has been practicing law for 29 years. She specializes in laboratory regulatory and compliance matters, and has counseled more than 500 […]